Member Info for glosman

Charlie1984,i am already a member,are they going to find out what is going on,we need some answers,is GR going to do a podcast or another webinar

they applied for extension before expiry last time ,so i would guess as we passed the 14th then DD is complete.As has been said they do not work weekends so hopefully RNS later today or tomorrow.GLA

if the 401 deal was close why would they need to raise over 1 million

he also stated it can take up to 6 months jonbhoy,i think most here are fed up with the BS from the BOD.

can i remind you all GM stated in the podcast that the regulators will take 3 to 4 months before they give their blessing for further trials on 401.So who is going to sign a deal for 401 without the regulators blessing?I will not be chucking any more in here for a few months as this will be played big time. GLA

i sent my proof of holding and all required for ID on 5 sept ,but have had no reply regarding where to pay today,so i guess i will not be able to take part in the IPO

i sent all that in to them dougal66,but i have not heard anything back.How about you

if they ask for another extension,then i hate to think how long it will take them to DFS,considering they said they wanted to fast track Zulu into production,surely they would want to get DD done and get started on works.

i registered for IPO and mt email from them stated payment needs to be with them by 14th,ie tomorrow ,but i have heard nothing about where to pay or who.I did say i would not invest anymore until the companygives us more details about what is happening and future plans

as GM stated in the podcast the regulators will take at least 3 to 4 months to give their blessing for further trials.Can either of you justify why anyone would sign up for a deal before we get the regulators blessings.I am not deramping ,i just want someone to answer that question

how can they sign a deal if the regulators will take 3 to 4 months at least before they give their blessing for further trials.He said in the podcast that the regulators have the information,but could take up to 6 months to give their blessing.So who is going to sign a deal before the regulators give their blessing.This is not a deramp,it was in the podcast.Can anyone say if a deal will be signed with regulator approval

GR and Fuad have always been happy to reply to emails from investors,i have spoken to Fuad in the past,so i have no reason to doubt CF73 has spoken to Fuad.We all know a lot of news is due for release soon.Things are about to change here,its been a long and painful journey so far.GLA

GR said we are fully funded for rest of year,by which time RHA should be producing,and i think we might have a little surprise about the figures.I still think RHA was held back to get the 90% ownership,we shall see shortly.GLA

just listen to first part of podcast about 401
http://www.proactiveinvestors.co.uk/companies/stocktube/10377/commercial-discussions-for-valirx-s-lead-cancer-drug-progressing-rapidly--10377.html

can anyone explain why a company would sign a deal to progress 401 to p3 when the regulators will take 3 to 4 months at least to give their blessing for further trials

inanaco,at the beginning of podcast he was on about 401 and clinical report is now with regulators and they could take 3 to 4 months to give their blessing on further trials possibility up to 6 months.My point is who would sign a deal to progress 401 without having the regulators blessing for several months.its in the podcast at the beginning

so regulators will take possibly up to six months to give their blessing for further trials. So who is going to sign a deal to progress the trial before regulators have given their blessing.Any thoughts on this ?

just one deal in over 12 months,what happened to all the wrn deals that were still able to complete

badshah13,it does not say early next year to start dosing,it just says next year.I agree this has been released to get a spike for a placing.I am not excited by this RNS.GLA

Partners external to ValiRx and ValiSeek will have substantial input into the trial design, with first dosing anticipated next year.
That does not suggest to me they are near signing a deal,if they stated early next year i would be a lot happier.I hope i am wrong as i am well under water with this share.GLA